JSPR
Jasper Therapeutics·NASDAQ
--
--(--)
--
--(--)
JSPR fundamentals
Jasper Therapeutics (JSPR) released its earnings on Nov 10, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -1.13 (YoY +8.87%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.13
+8.87%
Report date
Nov 10, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Jasper Therapeutics (JSPR) key financial stats and ratios, covering profitability, financial health, and leverage.
Jasper Therapeutics (JSPR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Jasper Therapeutics (JSPR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Jasper Therapeutics (JSPR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Jasper Therapeutics (JSPR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Jasper Therapeutics (JSPR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Jasper Therapeutics year over year?What were the key takeaways from Jasper Therapeutics’s earnings call?What factors drove the changes in Jasper Therapeutics's revenue and profit?What is Jasper Therapeutics's gross profit margin?What is the market's earnings forecast for Jasper Therapeutics next quarter?What were the key takeaways from Jasper Therapeutics's earnings call?Did Jasper Therapeutics beat or miss consensus estimates last quarter?What guidance did Jasper Therapeutics's management provide for the next earnings period?
